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What’s new? 
 We present a comprehensive up-to-date review of the evidence for the effectiveness
of Type 2 diabetes group-based interventions. This is the first review in the area to
complete a meta-regression.
 We report statistically significant results for improving HbA1c, fasting blood glucose,
body weight, waist circumference, triglycerides and diabetes knowledge, but clinical
improvement is more nuanced.
 Group-based interventions facilitated by a single discipline, multidisciplinary teams
or health professionals with peer supporters appear to be more effective at improving
HbA1c than peer-led interventions.
 
Abstract 
Aims  Patient education for the management of Type 2 diabetes can be delivered in various 
forms, with the goal of promoting and supporting positive self-management behaviours. This 
systematic review aimed to determine the effectiveness of group-based interventions 
compared with individual interventions or usual care for improving clinical, lifestyle and 
psychosocial outcomes in people with Type 2 diabetes. 
Methods  Six electronic databases were searched. Group-based education programmes for 
adults with Type 2 diabetes that measured HbA1c and followed participants for ≥ 6 months 
were included. The primary outcome was HbA1c, and secondary outcomes included fasting 
blood glucose, weight, BMI, waist circumference, blood pressure, blood lipid profiles, 
diabetes knowledge and self-efficacy. 
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Results  Fifty-three publications describing 47 studies were included (n = 8533 participants). 
Greater reductions in HbA1c occurred in group-based education compared with controls at 6–
10 months [n = 30 studies; mean difference (MD) = 3 mmol/mol (0.3%); 95% confidence 
interval (CI): –0.48, –0.15; P = 0.0002], 12–14 months [n = 27 studies; MD = 4 mmol/mol 
(0.3%); 95% CI: –0.49, –0.17; P < 0.0001], 18 months [n = 3 studies; MD = 8 mmol/mol 
(0.7%); 95% CI: –1.26, –0.18; P = 0.009] and 36–48 months [n = 5 studies; 
MD = 10 mmol/mol (0.9%); 95% CI: –1.52, –0.34; P = 0.002], but not at 24 months. 
Outcomes also favoured group-based education for fasting blood glucose, body weight, waist 
circumference, triglyceride levels and diabetes knowledge, but not at all time points. 
Interventions facilitated by a single discipline, multidisciplinary teams or health professionals 
with peer supporters resulted in improved outcomes in HbA1c when compared with peer-led 
interventions. 
Conclusions  Group-based education interventions are more effective than usual care, 
waiting list control and individual education at improving clinical, lifestyle and psychosocial 
outcomes in people with Type 2 diabetes. 
 
Introduction 
Patient education is an integral and vital component of successful diabetes care [1–3]. The 
main goal of diabetes patient education is to promote and support positive self-management 
behaviours to optimize metabolic control, improve long-term diabetes outcomes and quality 
of life (QOL), prevent complications, and reduce morbidity and mortality, while remaining 
cost-efficient [1,4]. Group-based education for individuals with Type 2 diabetes mellitus may 
be more cost-effective and efficient than individual education, due to the reduced time and 
funding required to educate numerous people in one sitting [5]. The potential advantages of 
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group-based education interventions over individual visits include time for the provision of 
more detailed information, decreased time demands on health workers, easily incorporating 
families and carers, and facilitating discussions and support from others facing the same 
challenges [6,7]. Clearly, the use of group-based education warrants further investigation. 
Three previous systematic reviews included group education for Type 2 diabetes. A Cochrane 
systematic review assessed the effects of group-based training on clinical, lifestyle and 
psychosocial outcomes in people with Type 2 diabetes compared with routine treatment, 
waiting list control or no intervention [8]. The review favoured group-based education, 
finding significant improvements in HbA1c levels, body weight and systolic blood pressure 
(BP), fasting blood glucose (FBG), a decreased need for diabetes medication and increased 
diabetes knowledge [8]. A subsequent publication in 2012, updating the original Cochrane 
review, supported the findings of the former, favouring group-based education, with 
significant reductions in HbA1c, FBG and body weight, and improvements in diabetes 
knowledge compared with controls [6]. Another recent systematic review [9] assessed the 
effect of diabetes self-management education and support methods, providers, duration and 
contact time on glycaemic control in adults diagnosed with Type 2 diabetes. The review 
included individual, group-based, combination and remote interventions for the management 
of Type 2 diabetes, with results suggesting that a combination of individual and group-based 
education was most effective at improving HbA1c (median 9.6 mmol/mol; 0.88%) when 
compared with controls [9]. 
These previous reviews had limitations. First, the searches are outdated and the number of 
published studies for group-based diabetes interventions has increased substantially since 
their completion. High heterogeneity precluded meta-analyses for several of the main 
outcomes, which were completed for just two studies [6,8]. Although both reviews found 
clinical and statistically significant changes in health outcomes, the exact mechanism or 
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‘active ingredient(s)’ of these complex interventions were not identified [6,8]. Both reviews 
only conducted follow-up analyses of the primary outcome up to 2 years from baseline [6,8]. 
The quality of the previous reviews was assessed using ‘A Measurement Tool to Assess 
Systematic Reviews’ (AMSTAR), a reliable and valid method for assessing the 
methodological quality of systematic reviews [10]. The AMSTAR scores were categorized in 
line with previous research [11,12], with scores of 0–4 classified as ‘low quality’, 5–8 
classified as ‘moderate quality’, and 9–11 classified as ‘high quality’. The Cochrane review 
[8] was assessed as a high-quality review (score: 9/11). This review lacked an assessment of 
publication bias and conflict of interest for the included studies. The review by Steinsbekk 
et al. [6] was assessed as a moderate quality review (score: 5/11); no protocol was available, 
grey literature and publication bias were not considered, a list of excluded studies was not 
provided, an assessment of conflict of interest for included studies was not explored and the 
scientific quality of the included studies was not used appropriately in formatting 
conclusions. The review by Chrvala et al. [9] was assessed as a moderate quality review 
(score: 7/11); grey literature and publication bias were not considered, a list of excluded 
studies was not provided and conflict of interest for included studies was not explored. The 
review had various limitations including: restricting included studies to English-language 
publications, including only randomized controlled trials, including interventions for 
individuals with either/both Type 1 and/or Type 2 diabetes, and an inability to conduct meta-
analyses [9]. 
Despite these systematic reviews providing evidence of effectiveness, group-based education 
interventions are often complex and the characteristics of the interventions vary greatly, for 
example, in the number of contact hours, number of sessions, number and characteristics of 
participants, group facilitator(s) qualifications, facilitator training, theoretical framework, and 
whether family, friends or carers can attend [6,8]. Health professionals may deter from 
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group-based education because the essential attributes for a successful group-based education 
programme are unknown. Furthermore, no specific evidence-based practice guidelines for 
group-based education in Type 2 diabetes have been identified internationally, inevitably 
resulting in wide variations in the programmes offered, and creating difficulty in the 
interpretation of evidence and its translation to a practice setting. 
This systematic review builds upon two of the previous reviews [6,8] and seeks to update the 
evidence for the effectiveness of group-based interventions for Type 2 diabetes management 
and investigate key attributes for successful group programs. It was hypothesized that: 
 group-based interventions for Type 2 diabetes would have greater reductions in 
HbA1c compared with controls in the short (6 months) and long (> 12 months) term; 
 group-based interventions for Type 2 diabetes would improve body weight, waist 
circumference, FBG, BP, lipid profiles, diabetes knowledge and self-efficacy, 
compared with controls; 
 variations in effect sizes could be attributed to study design (i.e. setting, control 
group, educator), and intervention characteristics (i.e. number of participants, 
intervention length, number of contact hours). 
 
Methods 
The study was registered with the International Prospective Register of Systematic Reviews 
PROSPERO (CRD42015027785). 
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Data sources and search strategy 
A systematic literature search was performed to retrieve publications on group-based 
education for the management of Type 2 diabetes in adults. The search was completed in 
three parts. First, electronic databases, including PubMed, the Cochrane Central Register of 
Controlled Trials (CENTRAL), Embase, CINAHL, PsycINFO and ERIC, were searched 
from commencement of records to 22 September 2015 (File S1). Second, hand searches of 
reference lists from previous reviews were completed [6,8]. Finally, the included studies were 
cross-referenced with the results of an updated search by the authors of the most recent 
review including studies up to May 2012 (email correspondence). No language or date 
restrictions were applied. Abstract-only publications were excluded and duplicate articles 
were removed prior to title and abstract screening. 
 
Inclusion criteria and study selection 
Group-based education intervention studies for participants diagnosed with Type 2 diabetes 
that reported randomized controlled trials, cluster randomized trial or controlled clinical trial  
study designs were included. Studies were included if the described intervention met the 
following criteria: adults aged  18 years; face-to-face, educative group-based interventions 
(including those with occasional adjunct individual consultations) for people with Type 2 
diabetes; a minimum of four participants and may include family and friends for support; a 
minimum of one session lasting for 1 h; groups delivered in primary or secondary care 
compared with a control or comparison group (usual care, waiting list control or individual 
intervention); and studies that measured HbA1c at both baseline and 6 or more months from 
baseline. Studies were excluded if participants were pregnant women or were diagnosed with 
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Type 1 diabetes, or interventions provided education in individual consultations, included 
only exercise prescriptions without education or were not conducted face-to-face. 
All studies were screened against the eligibility criteria by two independent reviewers (KOJ 
and LEB) using reference manager software EndNote (Thomson Reuters, New York, NY, 
USA). Conflicts were resolved by discussion between them. Studies that met the inclusion 
criteria or did not include sufficient information for screening in the title and abstract, were 
included for full-text review. Full-text versions of these articles were obtained and screened 
independently. Authors were contacted for missing data up to three times by email if the 
missing data affected assessment of the study’s eligibility, and were excluded if contact could 
not be made. 
 
Data extraction and quality assessment 
Data extraction was completed by the first author (KOJ) and confirmed for accuracy by an 
independent reviewer (JTK). Data extracted included: general information on the study 
design, trial characteristics, intervention details, participant characteristics, outcome 
measures, results and information for appraising the risk of bias. Study quality was assessed 
using the Cochrane risk of bias tool [13] by two independent reviewers (KOJ and LEB). 
Disagreements were resolved through discussion. Risk of bias was ranked as low, unclear or 
high depending on whether a study had any element of bias (e.g. selection, performance, 
detection, attrition, reporting and other bias). 
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Data synthesis and analysis 
Descriptive data from the included studies were summarized. Data were meta-analysed if the 
same measurement was used across three or more studies at the same time point. The primary 
outcome measure was change in HbA1c in group-based education vs. control. The secondary 
outcome measures were changes in FBG, weight, BMI, waist circumference, BP, total 
cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, diabetes knowledge and self-
efficacy. Prior to the meta-analyses, studies reporting FBG or lipid profile measures in mg/dl 
were converted to mmol/l; those reporting weight in lb were converted to kg. 
Summaries of effect estimates were calculated by meta-analysis using the DerSimonian and 
Laird random effects model in Review Manager (RevMan, v. 5.3) [14]. Continuous data 
using the same measures were analysed with a weighted mean difference in outcomes 
between the intervention and control groups, whereas continuous data collected using a 
variety of measures were assessed using the standard mean difference (SMD). Heterogeneity 
was assessed using the I-squared statistic and reported following the Cochrane Handbook 
[13]. 
Mean differences (MD) and 95% confidence intervals (CI) were calculated in RevMan and 
standard error was calculated in Microsoft® Excel using the 95% CIs for the meta-regression. 
Separate analyses for the effect of group-based interventions on HbA1c were performed for 
the following subgroups: control groups, delivery setting, insulin therapy, type of educator(s), 
training of educator(s), baseline HbA1c levels, theoretical model and intervention content, 
materials, length, number of sessions, contact time, number of participants and the 
inclusion/exclusion of family and/or friends. 
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Sensitivity analyses were conducted to explore the influence of study quality (overall risk of 
bias and reporting bias), on HbA1c outcomes (as measured closest to intervention completion) 
and heterogeneity. Reporting bias and selective outcome reporting were chosen for the 
sensitivity analysis because studies that did not report the pre-specified outcomes or failed to 
include the results for an expected outcome may be reporting only results supporting the 
studies’ aims or hypotheses. We also examined potential influences on the primary outcome 
for studies that had differences in HbA1c at baseline, large (defined as > 10%) compared with 
small attrition (defined as < 10%), and studies published in non-English journals due to 
potential publication bias. 
Subgroup analyses were also conducted to examine the effects of different educators (health 
professionals, health professionals with peer support, peer or lay-persons), disciplines (single 
discipline compared with multidiscipline) and studies that included participants taking (and 
not taking) insulin on the primary outcome HbA1c. 
In addition, a univariate meta-regression was completed to explore potential associations 
between the size of effect and varying study and intervention characteristics [15]. Variables 
were similar to those explored in the subgroup analyses. A meta-regression was performed 
using Stata statistical software [16]. 
Results 
Study selection 
The search identified 14 016 results, from which 9764 publications were screened against the 
selection criteria, leaving 298 studies for full-text review (Fig. 1). Forty-seven studies 
reported in 53 publications were included in the systematic review (references provided in 
File S2). 
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A total of 8533 participants were included in the 47 studies (intervention group n = 4416, 
control group n = 4117). The mean age of participants was 60 years. Men made up 44% of 
participants in the both the intervention (1917 of 4383) and control (1799 of 4086) groups. 
Three of the 47 included studies (6%) recruited only women. Known duration of diabetes was 
reported by 29 of the 47 studies (62%). Mean duration of diabetes was 8.9 years for 
participants in the intervention group, and 9.4 years in the control group. Mean HbA1c level at 
baseline was 67 mmol/mol (8.3%) for both groups and ranged between 39 and 111 mmol/mol 
(5.7%–12.3%) for the intervention group and between 40 and 115 mmol/mol (5.8%–12.7%) 
for the control group. In 38 (81%) studies, the mean HbA1c was > 53 mmol/mol (7%) for 
both the intervention and control groups. 
 
Study characteristics 
Study characteristics are detailed in Table S1. Of the 47 studies included, 40 reported the 
results of randomized controlled trials, four reported results of controlled clinical trials and 
three reported the results of cluster randomized controlled trials. Most of the studies were 
carried out in the USA (18; 38%), the UK (6; 13%) and Italy (5; 11%). Forty-two of the 
studies were published in English, two in Spanish [17,18], two in Italian [19,20] and one in 
Dutch [21]. The studies were published between 1988 and 2015, and the length of follow-up 
was 6–60 months from baseline. Intervention characteristics varied in materials provided, 
discipline(s) of group educators and theoretical model used, as summarized in Table S2. 
Studies were conducted predominantly in primary care settings (32; 68%), with 15 (32%) of 
the studies delivered in secondary or tertiary care settings, for example, hospital diabetes 
centres or tertiary hospitals. Four publications [22–25] reported on multiple arm studies. 
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Study quality 
Most studies were classified as having a moderate (31) or high (12) risk of bias, with four 
studies classified as having a low risk of bias (Table S3). Of the six risk of bias items, 
allocation concealment (selection bias), blinding of participants and personnel (performance 
bias), and blinding of outcome assessment (detection bias) were the least consistently 
described or were generally poorly conducted in the included studies (Fig. S1). 
 
Overall effects of group-based interventions for HbA1c 
A meta-analysis was conducted to assess the effect of group-based education compared with 
control for all 47 included studies (n = 7055) using the measure of HbA1c at the time point 
closest to the completion of each group-based education intervention (Fig. 2). Overall, 
compared with control, group-based intervention was effective in reducing HbA1c by 
4 mmol/mol (0.3%) (95% CI: –0.51, –0.17; P < 0.0001; I2 = 84%). Heterogeneity was 
statistically significant and potential reasons for this were explored with sensitivity analyses. 
The results of the meta-analyses for HbA1c and secondary outcome measures at various time 
points are provided in Table 1. 
Group-based interventions significantly reduced HbA1c post intervention at most time points 
compared with controls. HbA1c was significantly reduced at 6–10 months post baseline 
[n = 30 studies; MD = 3 mmol/mol (0.3%); 95% CI: –0.48, –0.15; P = 0.0002; I2 = 65%], 12–
14 months post baseline [n = 27 studies; MD = 4 mmol/mol (0.3%); 95% CI: –0.49, –0.17; 
P < 0.0001; I
2
 = 64%], 18 months [n = 3 studies; MD = 8 mmol/mol (0.7%); 95% CI: –1.26, 
–0.18; P = 0.009; I2 = 50%] and at 36–48 months [n = 5 studies; MD = 10 mmol/mol (0.9%); 
95% CI: –1.52, –0.34; P = 0.002; I2 = 93%]. By contrast, when eight studies comparing 
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group-based interventions with controls measured HbA1c at 24 months post baseline, there 
was no significant difference between the groups. This time point also had the highest 
heterogeneity (I
2
 = 94%). 
There was variation in effectiveness in reducing FBG when comparing group-based 
interventions with controls. Group-based education was significantly more effective at 
reducing FBG compared with controls at 12–14 months post baseline (n = 8 studies; 
MD = 0.68 mmol/l; 95% CI: –1.25, –0.11; P = 0.02; I2 = 55%). However, this was not the 
case for FBG when measured at 6–10 or 24 months post baseline. All time points were 
assessed as having significant heterogeneity. 
Group-based education was significantly more effective at reducing body weight compared 
with controls at both 6–10 months (n = 17 studies; MD = 1.22 kg; 95% CI: –2.22, –0.23; 
P = 0.02; I
2
 = 62%) and 12–14 months (n = 9 studies; MD = 1.43 kg; 95% CI: –2.09, –0.77; 
P < 0.0001; I
2
 = 0%). Despite the statistically significant improvements in body weight at 
two time points, group-based education was not effective at significantly reducing BMI. 
Group-based education was significantly more effective at reducing waist circumference at 
6–10 months (n = 5 studies; MD = 1.19 cm; 95% CI: –2.34, –0.05; P = 0.04; I2 = 58%). 
However, although waist circumference showed a trend for improvement with group-based 
education at 12–14 months, the difference between groups was not significant (n = 3 studies; 
MD = 0.79 cm; 95% CI: –1.96, 0.38; P = 0.19; I2 = 38%). 
Both systolic and diastolic BP were measured at five time points (6–10, 12–14 and 24 months 
post baseline). When pooled, changes in systolic and diastolic BP were not statistically 
different between groups for any of these intervals. In addition, there were no significant 
differences in total cholesterol between group-based interventions and controls at any time 
point. 
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There were no statistically significant differences in HDL-cholesterol between groups at any 
time point. Heterogeneity was significant at all time points. There were mixed results for 
LDL-cholesterol when measured at two time points, 6–10 and 12–14 months (Table 1). At 6–
10 months, the meta-analysis resulted in no significant differences between groups for LDL-
cholesterol (n = 12 studies; MD = 0.03 mmol/l; 95% CI: –0.13, 0.07; P = 0.59; I2 = 49%). 
The studies assessing LDL-cholesterol at 12–14 months showed a significant decrease in 
LDL favouring the control group (n = 5 studies; MD = 0.08 mmol/l; 95% CI: 0.01, 0.15; 
P = 0.04; I
2
 = 0%). Group-based education was significantly more effective at reducing 
triglycerides at 6–10 months (n = 14 studies; MD = 0.13 mmol/l; 95% CI: –0.24, –0.01; 
P = 0.03; I
2
 = 4%) and 24 months (n = 3 studies; MD = 0.32 mmol/l; 95% CI: –0.58, –0.06; 
P = 0.01; I
2
 = 8%). At 12–14 months, the difference between groups for triglycerides were 
not significant (n = 11 studies; MD = 0.04; 95% CI: –0.22, 0.14; P = 0.66; I2 = 68%). 
Diabetes knowledge was reported by 16 studies and measured using a range of validated 
questionnaires. Group-based education was significantly associated with improved diabetes 
knowledge at two time points: 6–10 months (n = 7 studies; SMD = 0.61; 95% CI: 0.14, 1.08; 
P = 0.01; I
2
 = 83%) and 12–14 months (n = 7 studies; SMD = 0.58; 95% CI: 0.08, 0.97; 
P = 0.02; I
2
 = 93%). Self-efficacy was reported by five studies at three time points (6, 12 and 
24 months). Group-based education showed a trend to improved self-efficacy at 12 months 
post baseline (n = 3 studies; SMD = 0.15; 95% CI: –0.02, 0.33; P = 0.08; I2 = 0%), however, 
these measures were not significant. In addition, QOL, depression, energy intake and 
physical activity levels were assessed (Table S4). 
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Subgroup analyses 
Analyses were completed for 13 subgroups using HbA1c at the point closest to the end of 
each of the group-based education interventions as the outcome measure (Table 2). 
The type of educator subgroup analysis resulted in a significant subgroup difference 
(P = 0.002), with peer- and/or lay-led group-based interventions having no significant 
influence on improving HbA1c (P = 0.80). Interventions facilitated by single disciplines 
(P = 0.0003), multidisciplinary teams (P = 0.02) or health professionals with peer supporters 
(P = 0.01) were effective at significantly improving HbA1c (Table 2 and Fig. S2). Types of 
educators were further analysed to individual disciplines included in the ‘single discipline’ 
group, finding that physician-, dietitian- and nurse-led group-based education interventions 
were effective (P < 0.00001) at improving HbA1c (Fig. S3). Heterogeneity for both subgroup 
analyses was significant (I
2
 = 79.1% and 89.2%, respectively). In addition, subgroup analysis 
of studies with regards to insulin therapy resulted in a significant subgroup difference 
(P < 0.00001), with interventions that excluded participants on insulin therapy resulting in 
greater reductions in HbA1c (Fig. S4). Heterogeneity for both subgroup analyses was 
significant (I
2
 = 69% and 88%, respectively). 
Sensitivity analyses 
Sensitivity analyses were performed to explore the influence of study quality and 
characteristics on post-baseline HbA1c outcomes (Table 3) and heterogeneity. Forest plots for 
sensitivity analyses are reported in Figs S5–S9. 
There were no significant differences in HbA1c outcomes when study quality and attrition 
were explored; all subgroups showed statistically significant improvements in HbA1c 
(P  0.05). However, subgroups of studies assessed as being at high risk of reporting bias 
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(Fig. S6), having baseline differences between groups (Fig. S7) and studies published in non-
English journals (Fig. S9) did not show significant improvements in HbA1c. 
 
Meta-regression 
We used study variables and intervention characteristics including theoretical model, 
discipline(s) of educator(s), educator training, materials provided, delivery in primary care, 
both groups HbA1c < 7% at baseline, intervention length, contact time, number of 
participants, number of sessions, and the inclusion of family and friends in a meta-regression 
to explore potential associations between the size of effect and study and intervention 
characteristics on HbA1c at post intervention. None of these variables explained significant 
portions of heterogeneity among the studies (Table S5). 
 
Discussion 
This study systematically evaluated the effectiveness of group-based education for the 
management of Type 2 diabetes in adults. Given the high prevalence of Type 2 diabetes and 
the need for effective intervention, a synthesis of the most up-to-date literature is required. A 
previous review included only studies published prior to January 2008 [6]. This study fills 
this important gap and attempted to expand our understanding of effective intervention 
components. 
Meta-analyses of the primary outcome measure, HbA1c, resulted in statistically significant 
improvements at 6–10, 12–14, 18 and 36–48 months, but unexpectedly, not at 24 months post 
intervention. The meta-analysis at this time point had the highest heterogeneity (I
2
 = 94%). 
One study [26], in which contact with intervention participants decreased after 6 months, 
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favoured the control group and appeared to be an outlier, with a mean difference increase in 
HbA1c of 0.60% (95% CI: 0.52, 0.68). When this, and three other studies [18,20,27] assessed 
as high risk, were excluded from the meta-analysis, heterogeneity decreased substantially 
(I
2
 = 0%) and HbA1c lowered in favour of the intervention group [n = 4 studies; 
MD = 6 mmol/mol (0.6%); 95% CI: –0.86, –0.32; P < 0.0001] at the 24-month time point. 
Statistically significant reductions ranged from 3 mmol/mol (0.3%) at 6–10 months when 
pooled for 30 studies to 10 mmol/mol (0.9%) at 36–48 months when pooled for five studies. 
Although these reductions did not reach 11 mmol/mol (1%), suggested as the level necessary 
to achieve clinical importance [28,29], similar-sized reductions in HbA1c are known to 
mediate the risk of Type 2 diabetes complications [30]. 
Variability in outcomes was found for some secondary outcome measures, specifically FBG, 
body weight, waist circumference, triglyceride levels and diabetes knowledge. For example, 
FBG was improved statistically by mean reductions of 0.68 mmol/l at 12–14 months, but not 
at other time points. Previous research suggests that improving FBG in people with Type 2 
diabetes can reduce the development or progression of microvascular complications and can 
improve QOL [31]. Ideally, FBG should be maintained < 7.2 mmol/l in individuals with 
Type 2 diabetes [32]. Although the data suggest statistical improvements, only two of the 
eight studies included in the meta-analysis of FBG at 12–14 months resulted in reductions of 
FBG to < 7.2 mmol/l, suggesting that the improvements in FBG may be less clinically 
important. This may indicate that group-based education programmes are not effective at 
improving various secondary outcome measures when compared with controls, or that further 
consideration of these measures is required. 
Body weight and waist circumference were statistically improved by group-based 
interventions at time points closer to intervention completion, indicating that interventions 
were effective at improving these measures; however, maintenance of these improvements 
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requires further consideration. Weight control is recognized as a central strategy in diabetes 
care [31], however, the reductions in body weight (range 0.62–1.43 kg) and waist 
circumference (range 0.79–1.19 cm) in this review are unlikely to be clinically important. It 
has been demonstrated that a sustained weight loss (> 12 months) of 5 kg in people with 
Type 2 diabetes is associated with a reduction in HbA1c of 6–11 mmol/mol (0.5%–1%) [33]. 
Furthermore, for overweight or obese individuals with Type 2 diabetes, a weight loss of at 
least 5% seems necessary to improve blood glucose, lipid profiles and blood pressure [34]. 
However, it is unclear whether the participants in the included studies were overweight or 
obese, and a recent study found that intensive lifestyle interventions focusing on weight loss 
in adults with Type 2 diabetes did not reduce the rate of cardiovascular events despite 
significant weight loss [35]. Waist circumference is a commonly utilized measure of total 
body fat, a useful predictor of visceral fat [36], and can be a better predictor of cardiovascular 
risk [37] than BMI. It is likely that the reductions in weight were not great enough to 
influence BMI measures. These results are in line with previous systematic reviews, which 
found no statistically significant differences in BMI between groups [6,8]. 
Despite improvement in various blood lipid (excepting LDL-cholesterol) and BP measures, 
statistical significance was not reached at most time points. There may be several reasons for 
this: the limited number of studies assessing or providing education on these measures, the 
lack of intervention focus on blood lipids or BP, the widespread and early use of 
pharmacological interventions, the inclusion of participants on cholesterol-reducing or 
hypotensive medications, and underpowered studies to detect changes in blood lipids or BP.
 
The results highlight an important area for future research, given that improvements in lipid 
measures and BP control in Type 2 diabetes can reduce the risk of death related to diabetes, 
macrovascular and microvascular complications and myocardial infarction [29]. 
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The meta-analyses indicate that group-based interventions are effective at improving diabetes 
knowledge, but no differences in self-efficacy were evident. Perceived self-efficacy describes 
a person’s confidence or belief about his or her personal capabilities to accomplish a task or 
change a behaviour [38]. The found improvement in diabetes knowledge is consistent with 
two previous systematic reviews [6,8]. Successful self-management of Type 2 diabetes 
requires sufficient knowledge of the condition and its treatment, and the performance of self-
management activities and skills [39], and knowledge is an essential prerequisite [1]. 
The subgroup analyses revealed that peer- or lay-led group-based interventions did not 
significantly reduce HbA1c; however, interventions facilitated by single disciplines, 
multidisciplinary teams or health professionals with peer supporters resulted in statistical 
improvements in HbA1c. Furthermore, subgroup analysis of single educator studies indicated 
that physician-, dietitian- and nurse-led group-based education interventions were equally 
effective at improving HbA1c levels. The International Diabetes Federation guideline 
recommends that an appropriately trained multidisciplinary team provides education to 
groups of people with diabetes [40]. It defines limited care as group education by a smaller 
team, for example, with a physician and diabetes educator or, in very limited situations, an 
appropriately skilled individual [40]. By contrast, and similar to the previous review [6], the 
results of this review indicate that educators from a single discipline providing group-based 
education to persons with Type 2 diabetes can be more effective than multidisciplinary 
teams. Multidisciplinary teams may result in reduced contact time with each educator, thus 
limiting the participant’s development of relationships and level of perceived support. 
Support from group educators can enhance the development of self-management skills in 
people with Type 2 diabetes [41–43], with researchers suggesting that this support can 
influence an individual’s motivation to self-manage their condition [44,45]. 
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Our results support the use of peer facilitators complementing health professionals, rather 
than replacing them [7]. Peer support can enhance and complement other healthcare services, 
can provide role-modelling and practical, emotional and ongoing support, and can assist 
individuals to follow management plans, cope with the stressors of chronic disease and 
remain motivated [46,47]. The benefits of peer support include the establishment of a non-
hierarchical, reciprocal relationship with the individual, and the ability to share knowledge, 
life experience and common illness experiences, which many health workers would not have 
[7]. 
Although HbA1c did improve statistically in both groups as expected, studies that excluded 
participants that used insulin showed greater improvements in HbA1c than studies that 
included them. This was an expected result, because insulin therapy lowers blood glucose and 
HbA1c, resulting in tighter glycaemic control [32]. 
Despite the lack of statistically significant differences between subgroups, some subgroup 
analyses resulted in significant improvements, whereas others did not. To improve HbA1c 
outcomes for individuals with Type 2 diabetes, the following characteristics of group-based 
interventions may be associated with greater effects: conducted in primary care settings; 
provide materials to participants; have < 10 sessions provided either in < 1 month, or over 7–
12 or 13–60 months; provide < 8, 8–12, 19–30 or 31 h or more of contact time; include < 20 
participants in each group; and include individuals with HbA1c levels > 53 mmol/mol (7%). 
Although not directly comparable because we did not reach a pooled reduction of HbA1c of 
11 mmol/mol (1%), these results differed from the findings from a previous systematic 
review which found that the only predictor of a reduction in HbA1c of 11 mmol/mol (1%) was 
contact time of 23.6 h [4]. Furthermore, a previous systematic review found that group-based 
interventions delivered in < 10 months, with > 12 h of contact time over 6–10 sessions were 
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most efficacious in improving HbA1c [6]. The reasons for the different results relative to the 
contact time are likely due to other intervention factors, such as intervention content, 
facilitators or intervention length. 
Finally, studies in which the content was facilitator-directed resulted in significant 
improvements in HbA1c, whereas patient-directed interventions did not. These results 
contradict the findings from previous studies, which support the use of a patient-centred 
approach, suggesting that engaging individuals in their healthcare decisions can enhance their 
adherence to therapy [32]. Patient-directed interventions, in which participants decide on the 
content covered in the intervention and can therefore explore their own agenda, interests and 
needs, have been suggested to be effective in improving participant knowledge, blood 
glucose levels, weight and medication usage, as well as assisting the development of self-
management behaviours [48,49]. Facilitator-directed programmes contain lesson plans with 
clearly defined content selected by intervention facilitators. This allows programmes to be 
replicated by multiple facilitators; however, they may be more likely to utilize a didactic 
facilitation style, which could reduce time for group interactions and discussion [48]. The 
subgroup analysis in the current study, however, was underpowered, with only four studies 
utilizing a patient-centred approach, compared with 43 studies utilizing a facilitator-directed 
approach. Furthermore, studies that compared group-based interventions to usual care were 
effective at improving HbA1c, whereas those compared with other comparators (e.g. 
individual education, waiting list control), did not significantly improve HbA1c. However, 
this analysis did not result in a significant difference between groups, and was underpowered, 
with 28 (65%) of the studies comparing to usual care controls. 
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Limitations 
Although our study has many strengths, there are several limitations. Using the AMSTAR 
quality assessment tool, our review is of high quality (10/11). A search of the grey literature 
in the area was not completed and may have resulted in publication bias. However, we 
conducted sensitivity analysis to consider the influence of publication bias when studies were 
published in non-English journals and found no differences in the primary outcome. Most 
studies included in the review were assessed as having a moderate (31 of 47 studies) or high 
(12 of 47 studies) risk of bias. As such, the results should be interpreted with caution. 
Thirteen studies were assessed as having a potential conflict of interest either due to partial 
funding or equipment donations by pharmaceutical companies, or possible financial gains to 
the authors from commercially available materials and training courses (Table S1). Only 5 of 
the 47 included studies measured hypoglycaemia, an important end point, unwanted 
consequence of therapy and commonly feared acute complication in Type 2 diabetes [31]. 
Furthermore, the authors were unable to explore the barriers and enablers regarding the 
implementation of education programmes because this information was not commonly 
provided in published reports. 
Numerous meta-analyses resulted in high heterogeneity between studies; however, this is 
common in allied health research, particularly in complex interventions, and was assessed 
comprehensively through sensitivity analyses, subgroup analyses and a univariate meta-
regression. Furthermore, the two previous systematic reviews also had high heterogeneity, 
with the Cochrane review reporting I
2
 scores between 0% and 96.4% [8] and a review by 
Steinsbekk et al. [6] reporting I
2
 scores between 0% and 85.5%. 
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Conclusions 
The 47 studies included in this systematic review provide evidence supporting the use of 
group-based education for the management of Type 2 diabetes to significantly improve 
HbA1c, FBG, body weight, waist circumference, triglycerides and diabetes knowledge. 
However, the results may not be clinically important and were complex, with most outcomes 
improving at time points proximal to the intervention, but others improving at more distal 
time points. In addition, the results should be interpreted with caution due to the high 
heterogeneity of some of the meta-analyses, as well as assessment of most of the included 
studies as having a moderate or high risk of bias. Group-based education interventions 
facilitated by single disciplines, multidisciplinary teams or health professionals with peer 
supporters result in improved outcomes in HbA1c when compared with peer-led interventions. 
The lack of statistical significance in all but two of the subgroup analyses may indicate that 
other factors such as peer identification, normalization and group interactions are the ‘active 
ingredient(s)’ and, as such, substantially influence the effectiveness of group-based education 
interventions for the management of Type 2 diabetes. Future research should explore these 
factors, as well as the cost-effectiveness of, and barriers and facilitators to implementing 
group-based education programmes for the management of Type 2 diabetes. Finally, future 
interventions should consider hypoglycaemia as an important end point. 
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FIGURE 1 Stages of study identification 
 
FIGURE 2 Effectiveness of group-based interventions compared with controls for Type 2 diabetes for HbA1c 
(%). Risk of bias: A, random sequence generation (selection bias); B, allocation concealment (selection bias); C, 
blinding of participants and personnel (performance bias); D, blinding of outcome assessment (detection bias); 
E, incomplete outcome data (attrition bias); F, selective reporting (reporting bias); G, other bias. 
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Table 1 Summary of meta-analysis results for primary and secondary outcome measures at various time points  
 
Outcome  Time 
point 
(months) 
No. 
studies 
No. 
participants 
(IG/CG) 
Mean 
difference 
(95% CI) 
P-
value 
Heterogeneity 
(%) (I
2
) 
Heterogeneity 
(P-value) 
HbA1c (%) 6–10 30 2155/1952 –0.31 (–
0.48, –
0.15) 
0.0002 65 < 0.00001 
 12–14 27 2233/2151 –0.33 (–
0.49, –
0.17) 
< 0.0001 64 < 0.00001 
 18 3 98/96 –0.72 (–
1.26, –
0.18) 
0.009 50 0.13 
 24 8 551/555 –0.33 (–
0.82, 
0.17) 
0.20 94 < 0.00001 
 36–48 5 747/689 –0.93 (–
1.52, –
0.34) 
0.002 93 < 0.00001 
Fasting blood 
glucose (mmol/l) 
6–10 10 454/461 –0.24 (–
0.95, 
0.47) 
0.51 79 < 0.00001 
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Outcome  Time 
point 
(months) 
No. 
studies 
No. 
participants 
(IG/CG) 
Mean 
difference 
(95% CI) 
P-
value 
Heterogeneity 
(%) (I
2
) 
Heterogeneity 
(P-value) 
 12–14 8 496/575 –0.68 (–
1.25, –
0.11) 
0.02 55 0.03 
 24 4 204/209 –0.10 (–
1.60, 
1.39) 
0.89 88 < 0.0001 
Weight (kg) 6–10 17 1341/1172 –1.22 (–
2.22, –
0.23) 
0.02 62 0.0003 
 12–14 9 804/760 –1.43 (–
2.09, –
0.77) 
< 0.0001 0 0.88 
 36–48 4 714/605 –0.62 (–
1.69, 
0.45) 
0.25 0 0.77 
BMI (kg/m
2
) 6–10 18 1019/1016 –0.00 (–
0.44, 
0.44) 
0.99 36 0.07 
 12–14 13 962/1082 0.19 (–
0.37, 
0.75) 
0.51 55 0.009 
 24 6 496/502 0.80 (–
0.93, 
2.54) 
0.36 89 < 0.00001 
Waist 
circumference 
(cm) 
6–10 5 520/466 –1.19 (–
2.34, –
0.05) 
0.04 58 0.05 
 12–14 3 579/509 –0.79 (–
1.96, 
0.38) 
0.19 38 0.20 
Systolic blood 
pressure (mmHg) 
6–10 17 1359/1218 0.12 (–
1.44, 
1.67) 
0.88 38 0.05 
 12–14 11 1087/1083 –0.49 (–
1.90, 
0.92) 
0.49 0 0.45 
 24 4 263/265 –0.68 (–
5.43, 
4.07) 
0.78 40 0.17 
 36–48 4 714/605 –1.71 (–
5.76, 
2.34) 
0.41 66 0.03 
Diastolic blood 
pressure (mmHg) 
6–10 17 1435/1261 –1.77 (–
3.73, 
0.20) 
0.08 92 < 0.00001 
 12–14 11 1087/1083 –0.80 (–
1.71, 
0.12) 
0.09 0 0.46 
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Outcome  Time 
point 
(months) 
No. 
studies 
No. 
participants 
(IG/CG) 
Mean 
difference 
(95% CI) 
P-
value 
Heterogeneity 
(%) (I
2
) 
Heterogeneity 
(P-value) 
 24 3 97/94 1.12 (–
1.77, 4) 
0.45 17 0.30 
 36–48 4 714/605 –1.13 (–
2.70, 
0.43) 
0.16 40 0.17 
Total cholesterol 
(mmol/l) 
6–10 15 1153/1117 –0.01 (–
0.16, 
0.14) 
0.87 75 < 0.00001 
 12–14 9 891/928 0.01 (–
0.12, 
0.15) 
0.84 44 0.07 
 24 3 241/243 –0.10 (–
0.56, 
0.36) 
0.67 81 0.005 
 36–48 3 692/583 –0.23 (–
0.65, 
0.18) 
0.27 88 0.0003 
HDL cholesterol 
(mmol/l) 
6–10 13 967/906 0.16 (–
0.09, 
0.41) 
0.22 99 < 0.00001 
 12–14 10 915/943 0.02 (–
0.02, 
0.07) 
0.28 74 < 0.0001 
 36–48 3 692/583 0.04 (–
0.10, 
0.18) 
0.59 94 < 0.00001 
LDL cholesterol 
(mmol/l) 
6–10 12 571/560 –0.03 (–
0.13, 
0.07) 
0.59 49 0.03 
 12–14 5 333/398 0.08 
(0.01, 
0.15) 
0.04 0 0.44 
Triglycerides 
(mmol/l) 
6–10 14 1105/1045 –0.13 (–
0.24, –
0.01) 
0.03 4 0.41 
 12–14 11 1045/1069 –0.04 (–
0.22, 
0.14) 
0.66 68 0.0005 
 24 3 118/119 –0.32 (–
0.58, –
0.06) 
0.01 8 0.34 
Outcome Time 
point 
(months) 
No. 
studies 
No. 
participants 
(IG/CG) 
Standard 
mean 
difference 
(95% CI) 
P-value Heterogeneity 
(%) (I
2
) 
Heterogeneity 
(P-value) 
Diabetes 
knowledge 
6–10 7 239/240 0.61 
(0.14, 
1.08) 
0.01 83 < 0.00001 
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Outcome  Time 
point 
(months) 
No. 
studies 
No. 
participants 
(IG/CG) 
Mean 
difference 
(95% CI) 
P-
value 
Heterogeneity 
(%) (I
2
) 
Heterogeneity 
(P-value) 
 12–14 7 609/682 0.58 
(0.08, 
0.97) 
0.02 93 < 0.00001 
Self-efficacy  12 3 256/272 0.15 (–
0.02, 
0.33) 
0.08 0 0.92 
 
IG, intervention group; CG, control group; CI, confidence interval. 
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Table 2 Subgroup analysis results for primary outcome measure (HbA1c; %) 
 
Analysis outcome No. 
studies 
No. participants 
(IG/CG) 
Mean difference 
(95% CI) 
Overall effect: 
P-value 
Heterogeneity (%) Subgroup differences: 
P-value 
Control group 47 3579/3476 – – – 0.60 
Usual care 28 2414/2322 –0.42 (–0.66, –0.18) 0.0007 88  
Waiting list control 4 243/251 –0.34 (–0.85, 0.18) 0.20 70  
Individual intervention 6 542/532 –0.05 (–0.50, 0.40) 0.82 81  
Usual care with written materials 6 315/412 –0.21 (–0.54, 0.12) 0.21 61  
Group education prior to usual care 3 65/63 –0.48 (–1.03, 0.07) 0.09 34  
Delivery setting 47 3579/3476 – – – 0.38 
Primary care 34 2858/2808 –0.28 (–0.41, –0.16) < 0.0001 59  
Other 13 721/668 –0.52 (–1.02, –0.01) 0.05 93  
Type of educators 47 3579/3476 – – – 0.002 
Peer or lay led 5 530/536 0.02 (–0.12, 0.16) 0.80 0  
Health professional led with peer 
support 
5 517/502 –0.27 (–0.48, –0.06) 0.01 0  
Single discipline 17 1054/1080 –0.56 (–0.86, –0.26) 0.0003 86  
Multidisciplinary 20 1478/1358 –0.24 (–0.43, –0.04) 0.02 61  
Training: 47 3579/3476 – – – 0.82 
Yes 34 2915/2814 –0.33 (–0.53, –0.13) 0.001 87  
No 13 664/662 –0.38 (–0.70, –0.05) 0.02 69  
Baseline HbA1c levels 47 3579/3476 – – – 0.52 
> 7 in both groups 38 3043/2937 –0.37 (–0.56, –0.17) 0.002 85  
< 7 in both groups 9 536/539 –0.24 (–0.60, 0.13) 0.21 82  
Insulin therapy 38 2978/2893 – – – < 0.0001 
Yes 20 1809/1661 –0.19 (–0.28, –0.10) < 0.0001 69  
No 18 1169/1232 –0.81 (–0.92, –0.70) < 0.00001 88  
Theoretical model 47 3579/3476 – – – 0.48 
Yes 24 2227/2089 –0.39 (–0.65, –0.12) 0.004 89  
No 23 1352/1387 –0.27 (–0.46, –0.09) 0.003 62  
Intervention content 47 3579/3476 – – – 0.75 
Facilitator–directed 43 3306/3226 –0.34 (–0.52, –0.15) 0.0003 85  
Patient–directed 4 273/250 –0.42 (–0.94, 0.09) 0.11 73  
Materials 47 3579/3476 – – – 0.90 
Yes 40 3182/3100 –0.34 (–0.53, –0.15) 0.0004 85  
No 7 397/376 –0.37 (–0.83, 0.09) 0.12 84  
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Analysis outcome No. 
studies 
No. participants 
(IG/CG) 
Mean difference 
(95% CI) 
Overall effect: 
P-value 
Heterogeneity (%) Subgroup differences: 
P-value 
Intervention length (months) 47 3579/3476 – – – 0.53 
< 1 6 875/790 –0.33 (–0.64, –0.02) 0.04 56  
1–3 8 585/546 –0.20 (–0.50, 0.10) 0.19 71  
4–6 11 501/486 –0.19 (–0.48, 0.10) 0.20 67  
7–12 13 824/850 –0.32 (–0.55, –0.09) 0.007 54  
13–60 9 794/804 –0.66 (–1.14, –0.18) 0.007 93  
Number of sessions 47 3579/3476 – – – 0.34 
< 5 13 1223/1208 –0.46 (–0.70, –0.23) < 0.0001 68  
6–10 21 1360/1294 –0.20 (–0.39, –0.01) 0.04 71  
11–20 8 707/678 –0.48 (–1.04, 0.09) 0.10 92  
> 21 5 289/296 –0.31 (–0.71, 0.09) 0.13 41  
Contact time (h) 47 3579/3476 – – – 0.72 
≤ 8 13 1168/1033 –0.45 (–0.74, –0.17) 0.002 72  
9–12 7 536/557 –0.35 (–0.59, –0.11) 0.004 55  
13–18 10 909/909 –0.19 (–0.74, 0.35) 0.48 96  
19–30 9 348/352 –0.42 (–0.77, –0.08) 0.02 58  
≥ 31 8 618/625 –0.25 (–0.42, –0.09) 0.003 0  
Number of participants 47 3579/3476 – – – 0.40 
4–10 32 2563/2426 –0.39 (–0.16, –0.17) 0.0006 87  
11–20 15 1016/1050 –0.25 (–0.48, –0.02) 0.03 64  
Family and friends 47 3579/3476 – – – 0.70 
Yes 29 2841/2700 –0.36 (–0.59, –0.13) 0.002 88  
No 18 738/776 –0.30 (–0.52, –0.08) 0.008 67  
 
IG, intervention group; CG, control group; CI, confidence interval. 
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Table 3 Sensitivity analysis results for primary outcome measure (HbA1c; %) 
 
Analysis 
outcome 
No. 
studies 
No. 
participants 
(IG/CG) 
Mean difference 
(95% CI) 
P-value Heterogeneity 
(%) 
Subgroup 
differences: 
P-value 
Overall risk 
of bias 
47 3579/3476 – – – 0.92 
Low 4 409/375 –0.40 (–0.75, –
0.06) 
0.02 52  
Moderate 31 2011/1963 –0.35 (–0.59, –
0.12) 
0.003 88  
High 12 1159/1138 –0.31 (–0.59, –
0.02) 
0.03 74  
Reporting 
bias 
47 3579/3476 – – – 0.38 
Low 38 2792/2734 –0.38 (–0.58, –
0.18) 
0.0002 86  
High 9 787/742 –0.22 (–0.52, 0.08) 0.16 69  
Baseline 
differences 
47 3579/3476 – – – 0.68 
Yes 10 737/695 –0.27 (–0.62, 0.07) 0.12 70  
No 37 2842/2781 –0.36 (–0.55, –
0.16) 
0.0004 86  
Dropout 47 3579/3476 – – – 0.09 
< 10% 
attrition 
14 1043/949 –0.53 (–0.72, –
0.34) 
< 0.00001 41  
> 10% 
attrition 
33 2536/2527 –0.27 (–0.49, –
0.05) 
0.02 88  
Translated 
publication 
47 3579/3476 – – – 0.48 
Yes 42 3313/3206 –0.36 (–0.55, –
0.18) 
< 0.0001 85  
No 5 409/375 –0.15 (–0.72, 0.42) 0.61 74  
 
IG, intervention group; CG, control group; CI, confidence interval. 
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Supplemental Data 
 
Supplemental Item S1: Search Strategy for PubMed 
We used the following search strategy to search Pubmed. The search strategy was adapted to 
search the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, CINAHL, 
PsycINFO, and ERIC. There were no language or date restrictions. 
 
Pubmed 
"Patient Education as Topic"[Mesh] OR "Self Care"[Mesh] OR "Behavior Therapy"[Mesh] 
OR "Group Processes"[Mesh] OR "Psychotherapy, Group"[Mesh] OR "Self-Help 
Groups"[Mesh] OR Patient education[tiab] or Self care[tiab] OR Self-care[tiab] OR Self 
management[tiab] OR Self-management[tiab] OR Behavior therapy[tiab] OR Behaviour 
therapy[tiab] OR Group process[tiab] OR Group processes[tiab] OR Group 
psychotherapy[tiab] 
AND 
"Diabetes Mellitus, Type 2"[Mesh] OR MODY[tiab] OR NIDDM[tiab] OR T2DM[tiab] OR 
((non insulin[tiab] OR noninsulin[tiab] OR “Type 2”[tiab] OR “Type II”[tiab] OR Ketosis-
Resistant[tiab] OR Ketosis resistant[tiab] OR Maturity-Onset[tiab] OR Maturity onset[tiab] 
OR Mature-onset[tiab] OR Mature onset[tiab] OR Adult-onset[tiab] OR Adult onset[tiab] OR 
Slow-onset[tiab] OR Slow onset[tiab] OR Stable[tiab]) AND Diabetes) 
AND 
Group[tiab] OR Groups[tiab] 
NOT 
"Diabetes Insipidus"[Mesh] OR Diabetes Insipidus[tiab] 
AND 
randomized controlled trial[Publication Type] OR controlled clinical trial[Publication Type] 
OR randomized[Title/Abstract] OR randomised[Title/Abstract] OR placebo[Title/Abstract] 
OR "drug therapy"[MeSH Terms] OR randomly[Title/Abstract] OR trial[Title/Abstract] OR 
groups[Title/Abstract] 
  
 2 
Supplemental Table S1: Study characteristics of included studies*  
Author, Year, 
Country 
Study design Length of 
follow up in 
months 
Setting No. at 
recruitment  
No. at 
follow up 
Mean baseline age 
(SD) 
Gender: 
% Male 
Mean 
baseline 
HbA1c  
Conflict 
of 
interest 
Adolfsson 2007, 
Sweden1 
RCT 12  Primary 
care  
IG: 42;  
CG: 46 
IG: 42;  
CG: 46 
IG: 62.4 (8.9);  
CG: 63.7 (9.0) 
IG: 57%;  
CG: 61%  
IG: 7.4;  
CG: 7.1 
No 
Brown 2002,  
USA2 
RCT 12  Primary 
care  
IG: 128;  
CG: 128 
IG: 115;  
CG: 115 
IG: 54.7 (8.2),  
CG: 53.3 (8.3) 
IG: 40%;  
CG: 32%  
IG: 11.8; 
CG: 11.8 
No 
Cade 2009,  
UK3 
RCT 12  Primary 
care  
IG: 122;  
CG: 127 
IG: 86;  
CG: 108 
IG: 65.8 (11),  
CG: 66.6 (11) 
IG: 62%;  
CG: 58%  
IG: 7.3;  
CG: 7.5 
No 
Cheyette 2007,  
UK4 
RCT 12  Secondary 
care  
IG: 29;  
CG: 20 
IG: 21;  
CG: 18 
IG: 56.7 (9.7);  
CG: 58 (10.7) 
IG: 48%;  
CG: 60%  
IG: 8.2;  
CG: 8.2 
No 
Clancy 2007,  
USA5 
RCT 12  Primary 
care 
IG: 96;  
CG: 90 
IG: 80;  
CG: 76 
IG: 55;  
CG: 57 
IG: 26%;  
CG: 30%  
IG: 9.3;  
CG: 8.9 
Yes 
Cohen 2011,  
USA6 
RCT 6  Primary 
care  
IG: 50;  
CG: 49 
IG: 48;  
CG: 48 
IG: 69.8 (10.7);  
CG: 67.2 (9.4) 
IG: 100%;  
CG: 96%  
IG: 7.8;  
CG: 8.1 
No 
Dalmau Llorca 2003,  
Spain7 
RCT 12  Primary 
care  
IG: 33;  
CG: 35 
IG: 35;  
CG: 38 
IG: 64.9 (8.2);  
CG: 65.6 (8.1) 
IG: 64.7%,  
CG: 35.3% 
IG: 7.2;  
CG: 6.6 
Unclear 
Davies 20088/ Khunti 
2012,  
UK9 
Cluster RCT 12/ 36  Primary 
care  
IG: 437;  
CG: 387 
IG: 404;  
CG: 345/  
IG: 332;  
CG: 272  
IG: 59.4 (11.6),  
CG: 61.01 (12.1) 
IG: 53%;  
CG: 57%  
IG: 8.3;  
CG: 7.9 
No 
Deakin 2006,  
UK10 
RCT 14  Primary 
care  
IG: 157;  
CG: 157 
IG: 150; 
CG: 141 
IG:  61.3 (9.7);  
CG: 61.8 (11) 
IG: 52% 
CG: 52%  
IG: 7.7;  
CG: 7.7 
Yes 
Delahanty 2015, 
USA11 
RCT 6  Primary 
care  
IG: 28,  
CG: 29 
IG: 26;  
CG: 28 
IG: 62 (9.6),  
CG: 61 (11.4) 
IG: 61%;  
CG: 59% 
IG: 8.1;  
CG: 8.3 
No 
Domenech 1995, 
Argentina12 
CCT 12  Primary 
care  
IG: 40;  
CG: 39 
IG: 40;  
CG: 39 
IG: 52.7 (3.1);  
CG: 53.1 (1.1) 
IG: 55%;  
CG: 56%  
IG: 9;  
CG: 9 
Yes 
Edelman 2010, 
USA13 
RCT 12.8  Primary 
care  
IG: 133;  
CG: 106 
IG: 122;  
CG: 89 
IG: 63 (9.4);  
CG: 60.8 (10) 
IG: 95.5%;  
CG: 96.2%  
IG: 9.2;  
CG: 9.2 
Unclear 
Forjuoh 2014, USA14 RCT 12  Primary 
care  
IG: 101;  
CG: 95 
IG: 86;  
CG: 73 
IG: 57.6 (10.9) 
CG: 57.6 (10.9) 
IG 46.5%,  
CG 44.2%  
IG: 9.2;  
CG: 9.0 
Unclear 
Gagliardino 2013, 
Argentina15 
RCT 42  Primary 
care  
G1: 117;  
G3: 117;  
G4: 117  
G1: 84;  
G3: 86;  
G4: 33 
G1 62 (8.4);  
G3 62.2 (8.4);  
G4 62.2 (8.4) 
G1 32.5%,  
G3 33.3%, 
G4 37.6%  
IG: 7.7;  
CG: 7.8 
No 
Gallotti 2003,  
Italy16 
CCT 36  Primary 
care  
IG: 22;  
CG: 22 
IG: 22;  
CG: 22  
IG & CG:  
56-73 yrs 
IG: 55%;  
CG: 55%  
IG: 6.9;  
CG: 6.8 
Unclear 
 3 
Heller 1988,  
UK17 
RCT 12  Secondary 
care  
IG: 36;  
CG: 39 
IG: 35;  
CG: 39 
IG 56.5 (55-58);  
CG 56.4 (53-59.9) 
IG 55%,  
CG 41%  
IG: 12.3; 
CG: 12.7 
Yes 
Hornsten 2005& 
2008,  
Sweden18, 19 
Cluster RCT 12/ 60  Primary 
care  
IG 44;  
CG: 60 
IG: 40;  
CG: 59/  
IG: 39;  
CG: 50 
IG: 63.6 (9.3);  
CG: 63.4 (9.1) 
IG: 52%; 
CG: 55%  
IG: 5.7;  
CG: 5.8 
No 
Huisman 2009, 
Netherlands20 
RCT 6  Secondary 
care  
IG: 53;  
CG: 38 
IG: 21;  
CG: 12;  
CG+ 
manual: 7 
IG: 60.07 (6.76);  
CG: 56.69 (9.88); 
CG + manual: 56.74 
(10.30) 
IG: 52%; 
CG: 46%;  
CG + 
manual: 42% 
IG: 7.3;  
CG: 7.2 
Unclear 
Kattelmann 2009, 
USA21 
RCT 6  Primary 
care  
IG: 57;  
CG: 57 
IG: 51;  
CG: 53 
Unclear Unclear IG: 8.9;  
CG: 8.6 
No 
Kronsbein 1988, 
Germany22  
CCT 12  Primary 
care  
IG: 50;  
CG: 49 
IG: 50;  
CG: 49 
IG: 65 (9);  
CG: 63 (8) 
IG: 42%; 
CG: 39% 
IG: 7.1;  
CG: 6.5 
Unclear 
Lorig 2009,     USA23 RCT 12  Primary 
care  
IG: 186;  
CG: 159 
IG: 161;   
CG: 133 
IG: 67.7 (11.9);  
CG: 65.4 (11.4) 
IG: 37.6%, 
CG: 33.8% 
IG: 6.7;  
CG: 6.7 
Yes 
Lozano 1999, Spain24 RCT 24  Primary 
care  
IG: 120; 
CG: 123 
IG: 115;  
CG: 119 
IG: 63.8;  
CG: 64.7 
IG: 48%, 
CG: 48%  
IG: 6.6;  
CG: 6.7 
Unclear 
McKibbin 2006, 
USA25 
RCT 6  Secondary 
care  
IG: 32;  
CG: 32 
IG: 28;  
CG: 29 
IG: 53.1 (10.4);  
CG: 54.8 (8.2) 
IG: 68%; 
CG: 62%  
IG: 7.4;  
CG: 6.7 
Unclear 
Miselli 2009,  
Italy26 
RCT 24  Primary 
care  
IG: 51;  
CG: 51 
IG: 51;  
CG: 51 
IG: 63.38 (9.68);  
CG: 63.70 (6.99) 
IG: 45.1%; 
CG: 66.7%  
IG: 8.7;  
CG: 8.8 
No 
Mohamed 2013, 
Qatar27 
RCT 12  Primary 
care  
IG: 215;  
CG: 215 
IG: 109;  
CG: 181 
IG: 52 (8.9);  
CG: 55 (10.7) 
IG: 37%; 
CG: 28% 
IG: 8.7;  
CG: 8.6 
No 
Muchiri 2015,  
South Africa28 
RCT 12  Primary 
care  
IG: 41;  
CG: 41 
IG: 38;  
CG: 38 
IG: 59.4 (6.9),  
CG: 58.2 (8.0) 
IG: 12.2%; 
CG: 14.6%  
IG: 10.8; 
CG: 11.4 
No 
Penckofer 2012, 
USA29 
RCT 6  Primary 
care  
IG: 38,  
CG: 36 
IG: 26;  
CG: 34 
IG: 54.8 (8.8),  
CG: 54 (8.4) 
IG: 0%;  
CG: 0% 
IG: 7.8;  
CG: 7.9 
No 
Pennings-Van der 
Eerden 1991, 
Netherlands30 
RCT 6  Primary 
care  
IG: 61;  
CG: 57 
IG: 43;  
CG: 40 
IG: 64.9 (9.77);  
CG: 63.86 (9.34) 
IG: 39.3%; 
CG: 52.6% 
IG: 8.0;  
CG: 7.7 
Yes 
Philis-Tsimikas 2011,  
USA31 
RCT 10  Primary 
care  
IG: 104;  
CG: 103 
IG: 69;  
CG: 87 
IG: 52.2 (9.6);  
CG: 49.2 (11.8) 
IG: 33.7%; 
CG: 25.2%  
IG: 10.5; 
CG: 10.3 
Yes 
Pieber 1995, 
Austria32 
CCT 6  Primary 
care  
IG: 45;  
CG: 49 
IG: 45;  
CG: 49 
IG: 63.9 (8.2);  
CG: 65.4 (11.2) 
IG: 42%; 
CG: 47%  
IG: 8.6;  
CG: 8.8 
Unclear 
 4 
Rickheim 2002, 
USA33 
RCT 6  Secondary 
care  
IG: 87,  
CG: 83 
IG: 43;  
CG: 49  
IG: 51.6 (9.2);  
CG: 52.9 (12.8) 
IG: 35.6%; 
CG: 32.5%  
IG: 8.9;  
CG: 8.0 
Yes 
Ridgeway 1999, 
USA34 
RCT 12  Primary 
care 
IG: 28;  
CG: 28 
IG: 18;  
CG: 20 
IG: 62;  
CG: 65 
IG: 33%; 
CG: 25%  
IG: 12.3; 
CG: 12.3 
Unclear 
Rosal 2005,  
USA35 
RCT 6  Primary 
care  
IG: 15;  
CG: 10  
IG: 14;  
CG: 9 
IG: 62.7 (8.1);  
CG: 62.4 (9.7) 
IG: 20%; 
CG: 20%  
IG: 7.7;  
CG: 9.3 
Yes 
Rosal 2011,  
USA36 
RCT 12  Primary 
care  
IG: 124;  
CG: 128 
IG: 115;  
CG: 119 
IG: 45-54 (32.3%), 
55-64 (29%);  
CG: 45-54 (27.3%), 
55-64 (36.7%) 
IG: 21.8%, 
CG: 25%  
IG: 8.9;  
CG: 9.1 
Yes 
Sarkadi 2004, 
Sweden37 
RCT 24  Primary 
care  
IG: 33;  
CG: 31 
IG: 33;  
CG: 31 
IG: 66.5 (10.7),  
CG: 66.4 (7.9) 
Unclear IG: 6.5;  
CG: 6.4 
Yes 
Scain 2009,  
Brazil38 
RCT 12  Tertiary 
care 
IG: 52;  
CG: 52 
IG: 52;  
CG: 52;  
IG: 59.3 (8.8);  
CG: 59.5 (10.2) 
IG: 44.2%; 
CG: 50%  
IG: 6.8;  
CG: 6.7 
Unclear 
Smith 2011,  
UK39 
Cluster RCT 24  Primary 
care  
IG: 192;  
CG: 203 
IG: 166;  
CG: 171 
IG: 66.1 (11.11);  
CG: 63.2 (11.04) 
IG: 54%; 
CG: 54%  
IG: 7.2;  
CG: 7.2 
No 
Sperl-Hillen 2011/ 
2013,  
USA40, 41 
RCT 6.8/ 12.8  Primary 
care  
IG: 243;  
IE: 246;  
CG: 134 
IG: 239;  
CG: 130;  
IE: 239/  
IG: 227;  
CG: 124;  
IE: 239 
IG: 61.2 (11.8);  
CG: 63.3 (11.5);  
IE: 61.6 (10.9) 
IG: 49%;  
CG: 53.7%;  
IE: 50.4%  
IG: 8.1;  
CG: 8.0 
Yes 
Toobert, 2003, USA42 RCT 6  Primary 
care  
IG: 163;  
CG: 116 
IG: 137;  
CG: 108 
IG: 61.1 (8);  
CG: 60.7 (7.8) 
IG: 0%;  
CG: 0%  
IG: 7.4;  
CG: 7.4 
No 
Toobert 2011A& 
2011B,  
USA43, 44 
RCT 12/ 24  Primary 
care  
IG: 142;  
CG: 138 
IG: 99;  
CG: 107/  
IG: 97;  
CG: 93 
IG: 55.6 (9.7);  
CG: 58.7 (10.3) 
IG: 0%;  
CG: 0%  
IG: 8.4;  
CG: 8.2 
No 
Torres Hde 2009, 
Brazil45 
RCT 6  Secondary 
care  
IG: 54;  
CG: 50 
IG: 31;  
CG: 26 
IG: 61.7 (10.5);  
CG: 59.4 (10.4);  
IG: 24.1%; 
CG: 26%  
IG: 9.3;  
CG: 9.3 
Unclear 
Trento 2001/ 2002/ 
2004,  
Italy46-48 
RCT 24/ 48/ 60  Secondary 
care  
IG: 56;  
CG: 56 
IG: 43;  
CG: 47/ 
IG: 45;  
CG: 45/  
IG: 42;  
CG: 42  
IG: 63 (37-82);  
CG: 64 (45-80) 
IG: 51%; 
CG: 64%  
IG: 7.4;  
CG: 7.4 
No 
Trento 2008, 
Italy49 
RCT 24  Secondary 
care  
IG: 25;  
CG: 24 
IG: 24;  
CG: 21 
IG: 64.6 (9.3);  
CG 68.1 (7.1) 
IG: 52%; 
CG: 67%  
IG: 7.8;  
CG: 7.8 
No 
 5 
Trento 2010,    Italy50 RCT 48 Secondary 
care  
IG: 421;  
CG: 394 
IG: 315;  
CG: 266 
IG: 69 (8.4);  
CG: 69.6 (8.4) 
IG: 48%; 
CG: 54%  
IG: 8;  
CG: 8 
No 
Vadstrup 2011, 
Denmark51 
RCT 6  Secondary 
care  
IG: 70;  
CG: 73 
IG: 61;  
CG: 60 
IG: 58.5 (9),  
CG: 58 (10.3) 
IG: 59%; 
CG: 60%  
IG: 7.9;  
CG: 7.8 
Yes 
Yoo 2007,  
Korea52 
RCT 18  Secondary 
care  
IG: 25;  
CG: 23 
IG: 25;  
CG: 23 
IG: 55.32 (7.56);  
CG: 55.08 (7.175) 
IG: 32%; 
CG: 34.8% 
IG: 8.3;  
CG: 8.7 
No 
Zapotoczky 2001, 
Austria53 
RCT 12  Secondary 
care  
IG: 18;  
CG: 18 
IG: 18;  
CG: 18 
IG: 62 (8.2);  
CG: 53 (11.4) 
IG: 44%; 
CG: 28%  
IG: 8.6;  
CG: 8.0 
Unclear 
No.= number; RCT= Randomised controlled trial; CCT= Controlled clinical trial; IG= Intervention group; CG= Control group; IE= Individual intervention; 
SD= standard deviation; HbA1c= glycated haemoglobin 
 
* A list of excluded studies is available on request from the first author. 
  
 6 
Supplemental Table S2: Intervention characteristics of included studies  
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Adolfsson 
2007, 
Sweden1 
7 Empowerment 
group education 
Usual care 5-8 12.5- 15  4-5 No Empowerment, 
motivation, 
learning 
principles 
Yes (document 
and guidelines 
for facilitators) 
Physicians, 
diabetes 
specialist 
nurses 
Yes  
Brown 2002,  
USA2 
12 Group education 
program  
Waiting list  8  52 26 Yes Not stated Yes (videos, 
lab results)  
Bilingual 
Mexican 
American 
nurses, 
dietitians, 
community 
workers 
Yes  
Cade 2009, 
UK3 
1.75 Expert Patient 
Program (EPP) 
(adapted for 
Type 2 diabetes) 
Usual care 12-16 14  7 Yes Not stated Yes (written 
materials plus 
booklet) 
Peer or lay 
led 
Yes  
Cheyette 
2007,  
UK4 
4  Weight No More 
program 
Usual care 8-10 12  8 No Not stated Yes (visual 
teaching aids, 
food diaries) 
Dietitian, 
physio, 
diabetes 
nurse 
specialist  
Not 
stated 
Clancy 2007,  
USA5 
12  Group visits Usual care  14-17  24  12  Yes Not stated No  Primary care 
internal 
medicine 
physicians, 
registered 
nurses 
Yes 
 7 
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Cohen 2011, 
USA6 
6  VA MEDIC-E 
(Veterans 
Affairs 
Multidisciplinary 
Education and 
Diabetes 
Intervention for 
Cardiac Risk 
Reduction-
Extended) 
Usual care 4-6 15.5  9 Yes Not stated Yes 
(cardiovascular 
report card, 
videos; 
Powerpoint 
slides; food 
log; 
Pedometers) 
Pharmacist 
led, dietitian, 
nurse, 
physical 
therapist 
Not 
stated 
Dalmau 
Llorca 2003, 
Spain7 
12  Group education  Individual 
education 
5 3  6 Yes Not stated Yes (food 
photographs, 
written 
information; 
blackboards, 
transparencies 
and slides) 
Medical 
resident, 
nurse  
Not 
stated 
Davies 
20088/ 
Khunti 2012,  
UK9 
1 day/ 2 
half days 
Structured group 
education 
program 
Usual care 8 (4 to 
16) 
6  1 to 2 Yes Leventhal's 
common sense 
theory, dual 
process theory, 
social learning 
theory; Patient 
empowerment 
Yes (patient 
resources) 
Registered 
dietitians, 
practice 
nurses or 
nurse 
specialists 
Yes 
Deakin 2006,  
UK10 
1.5 X-PERT 
program 
Individual 
education  
Average 
16 
12  6 Yes Patient 
empowerment, 
discovery 
learning 
Yes (patient 
manual)  
Diabetes 
research 
dietitian  
Not 
stated 
Delahanty 
2015,  
USA11 
4.75 Group lifestyle 
intervention 
(GLI) adapted 
‘Look Ahead’  
Individual 
education 
8-10 28.5 19 Not 
stated 
Not stated Yes (Look 
AHEAD group 
materials) 
Dietitians Yes  
 8 
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Domenech 
1995, 
Argentina12 
1 Group-based 
structured 
teaching/ 
treatment 
program 
Usual care 5-8 6-8 4 Yes Not stated Yes (flip-
charts, food 
photographs, 
question cards, 
individual log 
books, patient 
booklet) 
Physicians Yes 
Edelman 
2010,  
USA13 
12  Group Medical 
Clinics 
Usual care   7-9 10.5-14  7 Yes Not stated No  Primary care 
general 
internist, 
pharmacist, 
nurse or 
certified 
diabetes 
educator 
Yes 
Forjuoh 
2014,  
USA14 
1.5 Intervention: 
Group program 
(Stanford 
CDSMP)  
Usual care 
(with 
written 
materials) 
7-17 15 6 Yes Not stated Yes 
(companion 
book, audio 
relaxation tape) 
Stanford-
certified 
CDSMP lay 
leaders and 
master 
trainers  
Yes 
Gagliardino 
2013, 
Argentina15 
6  Patient 
education- 
Diabetes 
Structured 
Education 
Courses for Type 
2 diabetes 
Usual care 
(with 
written 
materials) 
6-10 7.5- 10  5 Yes Not stated Yes (Illustrated 
materials, 
programme 
book, 
questionnaire 
cards, 
individual log-
book, patient 
book) 
Physicians Yes (G4 
only)  
Gallotti 
2003,  
Italy16 
36 Group program Usual care  11 54 36 No Not stated Yes (manual)  Medical 
doctors 
Yes 
 9 
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Heller 1988, 
UK17 
6 Intervention: 
Group program  
Usual care  4-6  7.5 5 Yes Not stated Yes (video 
tape, simple 
explanatory 
book) 
Diabetes 
nurses, 
dietitian 
Not 
stated 
Hornsten 
2005 & 
2008, 
Sweden18, 19 
9  Educational 
intervention 
(focus on 
personal 
understanding of 
their illness) 
Usual care  5-8 20 10 No Patient-
directed, 
patient-
centred, model 
of chronic 
illness 
No Diabetes 
nurses, nurse 
as moderator 
Yes 
Huisman 
2009, 
Netherlands20 
6  Self-regulation 
weight reduction 
intervention  
Usual care, 
or usual 
care (with 
written 
materials) 
10-15  16 8 Yes Self-regulation 
principles, 
motivational 
interviewing 
Yes 
(workbook, 
pedometer) 
Health 
psychologist 
Not 
stated 
Kattelmann 
2009,  
USA21 
6  The Medicine 
Nutrition Wheel 
Nutrition Model 
education 
lessons 
Usual care  5-9  18-21 6 Yes Empowerment Yes (Medicine 
Wheel Model 
for Native 
Nutrition, 
Powerpoint 
Presentations, 
individualized 
meal plan) 
Registered 
dietitian, 
tribal 
member 
Yes 
Kronsbein 
1988, 
Germany22 
1 Group structured 
treatment and 
teaching 
program (DTTP)  
Waiting list 4-6 6-8 4 Not 
stated 
Not stated Yes (flip-
charts, food 
photographs, 
diabetes-related 
question cards, 
patients' log-
books) 
Physicians, 
physician 
assistants 
Yes 
Lorig 2009, 
USA23 
1.5 Diabetes self-
management 
program 
(DSMP)  
Usual care 10-15  15 6 Yes Not stated Yes (book) Peer leaders Yes 
 10 
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Lozano 
1999,  
Spain24 
24  Health 
educational 
workshops 
Usual care  12-14 6 4 Yes Not stated Yes (handouts, 
food 
photographs, 
self-care 
devices, insulin 
pen) 
Nurses No  
McKibbin 
2006,  
USA25 
6  Diabetes 
Awareness and 
Rehabilitation 
Training 
(DART) 
Usual care 
(with 
written 
materials) 
32 36 24 Not 
stated 
Social 
cognitive 
theory 
Yes (handouts, 
educational 
materials, 
pedometers, 
mnemonic aids, 
printed 
materials) 
Diabetes 
educators, 
dietitians 
Not 
stated 
Miselli 2009,  
Italy26 
24 ROMEO Usual care   6-10  7 7 No Not stated Not stated Doctor, 
dietitian, 
nurse 
Not 
stated 
Mohamed 
2013,  
Qatar27 
1 Group-based 
intervention 
Usual care 
(with 
written 
materials) 
10-20 12- 16 4 Yes Empowerment, 
health belief 
models  
Yes 
(educational 
booklet for 
self-
management, 
pictorial 
materials, 
questionnaires) 
Physicians Yes 
Muchiri 
2015,  
South 
Africa28 
9  Structured 
nutrition 
education (NE) 
program  
Usual care 
(with 
written 
materials) 
6-10 25- 29 14 Yes Social 
Cognitive 
Theory, Health 
Belief Model, 
Knowledge 
Attitude 
Behaviour 
model 
Yes (education 
materials, 
diabetes 
education flip 
charts, hands 
on activities, 
demonstrations, 
food displays 
and vegetable 
gardening) 
Sub-district 
dietitian, 
final-year 
nutrition and 
food science 
student, 
experienced 
dietitian, 
sub-district 
horticulture 
officer  
Yes 
 11 
Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Penckofer 
2012,  
USA29 
5.5 Study of 
Women's 
Emotions and 
Evaluation of a 
Psycho 
educational 
(SWEEP) 
program 
Usual care  10-12 10  10 No Cognitive 
behavioural 
theory (CBT) 
Yes 
(progressive 
muscle 
relaxation CD, 
video, 
workbook, log 
book) 
Nurse Yes 
Pennings-
Van der 
Eerden 1991, 
Netherlands30 
1.75 Education 
program  
Usual care  8-10 21-28 7 Yes Not stated Yes (written 
information, 
audio-visual 
aids, 
demonstration 
materials) 
Physicians, 
dietitians, 
diabetologist, 
diabetes 
nurse 
Not 
stated 
Philis-
Tsimikas 
2011,  
USA31 
10  Project Dulce 
diabetes self-
management 
classes  
Usual care  6-12 32  16 Yes Not stated Yes (handouts)  Lay 
community 
health 
workers 
Yes 
Pieber 1995, 
Austria32 
1  Diabetes 
treatment and 
teaching 
program (DTTP)  
Waiting list 4-8 6-8 4 No Not stated Yes GP's, office 
staff 
Yes 
Rickheim 
2002,  
USA33 
6  Group 
intervention  
Usual care  4-8  7 4 Yes Adult learning 
model, public 
health nursing 
model, health 
belief model, 
transtheoretical 
model 
Yes  Nurse, 
dietitian 
Yes 
Ridgeway 
1999,  
USA34 
12 Education/ 
behaviour 
modification  
Usual care 14 10.5  7 Not 
stated 
Not stated Yes (teaching 
slides, 
handouts) 
Registered 
nurse, 
registered 
dietitian, 
diabetes 
educators, 
physicians  
Not 
stated 
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Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Rosal 2005, 
USA35 
2.5 Group based 
intervention  
Usual care 15 25 to 30  10 No CBT, patient-
centred 
counselling, 
social 
cognitive 
theory 
Yes (log book, 
glucose meter, 
step counter, 
large visuals 
depicting 
traffic light 
system, dietary 
guidelines, 
soap opera 
drama) 
Diabetes 
nurse, 
nutritionist, 
assistant 
Yes 
Rosal 2011, 
USA36 
11 The Latinos en 
Control 
intervention 
Usual care  Up to 
15 
30 20 Yes Social 
cognitive 
theory 
Yes (log book, 
glucose meter, 
step counter, 
visuals of 
traffic light 
system, dietary 
guidelines, 
soap opera 
drama) 
Nutritionist 
or health 
educator, 
assistant 
(trained lay 
individuals) 
Yes 
Sarkadi 
2004, 
Sweden37 
12 Experience-
based group 
educational 
program 
Waiting-list  8-10 36  12 Not 
stated 
Not stated Yes (video, 
game, booklet) 
Pharmacists Yes 
Scain 2009, 
Brazil38 
1 Structured group 
education 
program based 
on the Latin 
American 
Diabetes 
Association 
program for 
health care 
providers 
Usual care 8-10 8 4 No Not stated Yes (brochure, 
log book, 
leaflet with 
anthropometric 
data and test 
results, recipes, 
cooking 
suggestions) 
Nurse 
educator 
No 
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Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Smith 2011, 
UK39 
24 Peer support 
meetings  
Usual care 10 9- 13.5  9 No Social support 
theory 
Yes 
(educational 
resources; 
target card, 
video/ DVD, 
pedometer, 
laminated topic 
sheets) 
Trained peer 
supporters  
Yes  
Sperl-Hillen 
2011/ 2013, 
USA40, 41 
1 Group education 
using the US 
Diabetes 
Conversation 
Map program: 
IDEA study 
Usual care; 
and 
individual 
education  
8-10 8 4 Yes Patient-
centred, non-
didactic 
approach using 
the US 
Diabetes 
Conversation 
Map   
Yes 
(Conversation 
Map support 
materials) 
Certified 
diabetes 
educators 
(nurses, 
dietitians) 
Yes 
Toobert, 
2003,  
USA 
42 
6 Mediterranean 
Lifestyle 
Program (MLP) 
Usual care 5-10 116  6 Not 
stated 
Social 
Cognitive 
Theory, Goal 
Systems, 
Social 
Ecological 
Theory 
Yes (program 
materials) 
Registered 
dietitian, 
exercise 
physiologist, 
stress-
management 
instructor, 
professional, 
lay support 
group leaders 
Yes 
Toobert 
2011A & 
2011B, 
USA43, 44 
12/ 24 Viva Bien! 
Group education 
program  
Usual care 5-10 164/ 200 36/ 45 Yes Behaviour 
change theory  
Yes (stress 
management 
CDs, recipes, 
pamphlets) 
Physician, 
dietitian, 
exercise 
physiologist, 
yoga/ 
meditation 
instructor, 
support 
group leaders 
Yes 
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Author, 
Year, 
Country 
INT 
duration 
(mths) 
INT Control 
Group 
No. per 
group 
Contact 
time 
(hrs) 
No. of 
sessions 
Family/ 
friends 
included 
Theory Materials 
(type) 
Facilitator/s Training  
Torres Hde 
2009, 
Brazil45 
3  Group meetings  Individual 
intervention 
Average 
13 
22 11 Yes Social learning 
theory, health 
belief model 
Yes 
(educational 
pamphlets, 
videos) 
Nurse-led, 
doctor, 
nutritionist, 
physio, OT 
Yes 
Trento 2001/ 
2002/ 2004, 
Italy46-48 
24/ 48/ 
60 
Structured 
education 
programme  
Usual care  9-10 8 / 15/ 19 8/ 15/ 
19 
Yes  Systemic 
education 
approach 
Yes (visual 
aids, food, 
graduated 
containers, flip 
chart) 
Hospital 
physicians 
Not 
stated 
Trento 2008, 
Italy49 
24  Group education 
sessions  
Usual care  8-9 4-6.5 hrs 4-6 Yes Adult learning 
theory 
Yes 
(operational 
manual, 
brochures) 
Nurses, 
dietitian 
Yes 
Trento 2010, 
Italy50 
48 Structured 
education 
programme  
Usual care  10 14 hours 14 Yes Systemic 
education 
approach 
Yes (as per 
Trento 2001) 
Physicians Yes 
Vadstrup 
2011, 
Denmark51 
6  Group-based 
rehabilitation 
programme  
Individual 
education  
8 17 hrs 
education 
9 Not 
stated 
Motivational 
interviewing; 
empowerment 
approach 
Not stated Nurse, 
physio, 
podiatrist, 
dietitian 
Yes 
Yoo 2007, 
Korea52 
13 Comprehensive 
Lifestyle 
Modification 
Program 
(CLMP) 
GBE then 
usual care 
5-8 25 hrs 25 Not 
stated 
Self-efficacy Not stated Nurse 
researchers  
Yes 
Zapotoczky 
2001, 
Austria53 
10 Psycho 
educational 
group training 
GBE then 
usual care 
18 15 hrs 10 Not 
stated 
Learning 
theory 
Not stated Clinical 
dietitian 
Yes 
INT= Intervention; Physio= physiotherapist; OT= occupational therapist; IDEA= Interactive Dialogue to Educate and Activate; US= United States; mths= months; 
hrs= hours; GBE= group-based education
 15 
Supplemental Table S3: Risk of bias summary of studies included in systematic review*  
Author, Year, Country Overall Risk 
of Bias 
Random 
Sequence 
Generation 
Allocation 
Concealment 
Blinding Incomplete 
Outcome 
Data 
Selection 
Outcome 
Reporting 
Other 
potential 
sources of bias 
Adolfsson 2007, Sweden1 Moderate Unclear Unclear Unclear Low Low Low 
Brown 2002, USA2 Moderate Unclear Unclear Low Low Low Low 
Cade 2009, UK3 Moderate Unclear Unclear Unclear Low Low Low 
Cheyette 2007, UK4 Moderate Unclear Unclear Unclear High Low Low 
Clancy 2007, USA5 High Low Unclear Low Low High Low 
Cohen 2011, USA6 Moderate Unclear Unclear Unclear Low Low Low 
Dalmau Llorca 2003, Spain7 Moderate Low Unclear Unclear Low Low Low 
Davies 20088/ Khunti 2012, 
UK9 
High Low Unclear Unclear Low High Low 
Deakin 2006, UK10 Low Low Low Low Low Low Low 
Delahanty 2015, USA11 Moderate Unclear Unclear High Low Low Low 
Domenech 1995, Argentina12 High High Unclear Unclear High High High  
Edelman 2010, USA13 Low Low Low Low Low Low Low 
Forjuoh 2014, USA14 Moderate Unclear Unclear High Unclear High Unclear 
Gagliardino 2013, 
Argentina15 
Moderate Unclear Unclear High Low Low Low 
Gallotti 2003, Italy16 High High Unclear Unclear Unclear High Unclear 
Heller 1988, UK17 Moderate Unclear Unclear Unclear Low Low Unclear 
Hornsten 2005 & 2008, 
Sweden18, 19 
High Low Unclear Unclear Low High Low 
Huisman 2009, 
Netherlands20 
Moderate Unclear Unclear Unclear Low Low Low 
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Kattelmann 2009, USA21 High Low Unclear High High High Low 
Kronsbein 1988, Germany22  High High Unclear Unclear Low Low Low 
Lorig 2009, USA23 Moderate Low Unclear Unclear High  Low High 
Lozano 1999, Spain24 High High Unclear Unclear Low Low Unclear 
McKibbin 2006, USA25 Moderate Unclear Unclear Unclear Low Low Low 
Miselli 2009, Italy26 Moderate Unclear Unclear Unclear Unclear Low Unclear 
Mohamed 2013, Qatar27 Moderate Low Unclear Unclear Low Low Low 
Muchiri 2015, South Africa28 Low Low Low Low Low Low Low 
Penckofer 2012, USA29 Moderate Low High High Low Low Low 
Pennings-Van der Eerden 
1991, Netherlands30 
High Unclear Unclear Unclear High High Unclear 
Philis-Tsimikas 2011, USA31 Moderate Low Unclear Low Low Low Low 
Pieber 1995, Austria32 High High Unclear Unclear Low Low Low 
Rickheim 2002, USA33 Moderate Low Unclear Unclear Low Low Low 
Ridgeway 1999, USA34 Moderate Unclear Unclear Unclear Low Low Low 
Rosal 2005, USA35 Moderate Unclear Unclear Unclear Low Low Low 
Rosal 2011, USA36 High Low Unclear Low High Low Low 
Sarkadi 2004, Sweden37 Moderate Low Low High High High Unclear 
Scain 2009, Brazil38 Moderate Low Unclear Unclear Low Low Low 
Smith 2011, UK39 High Low High High Low Low Low 
Sperl-Hillen 2011/ 2013, 
USA40, 41 
Moderate Low Unclear Unclear Low Low Low 
Toobert, 2003, USA42 Moderate Unclear Unclear Unclear Low Low Low 
Toobert 2011A & 2011B, 
USA43, 44 
Low Low Unclear Low Low Low  Low 
Torres Hde 2009, Brazil45 Moderate Low Unclear Unclear Low Low Low 
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Trento 2001/ 2002/ 2004, 
Italy46-48 
Moderate Low Unclear Low Low Low Low 
Trento 2008, Italy49 Moderate Low Unclear Unclear Low Low Low 
Trento 2010, Italy50 Moderate Low Unclear Unclear Low Low Low 
Vadstrup 2011, Denmark51 Moderate Low Low High Low Low Low 
Yoo 2007, Korea52 Moderate Low Unclear Unclear Low Low Low 
Zapotoczky 2001, Austria53 Moderate Unclear Unclear Unclear Low Low Low 
* Studies were ranked into three categories: a. all quality criteria met: low risk of bias; b. one of more of the quality criteria only partly met: moderate risk of 
bias; c. one or more criteria not met: high risk of bias. 
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Supplemental Figure S1: Overall Risk of bias for included studies 
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Supplemental Figure S2: Forest plot- Subgroup analysis of group educators 
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Supplemental Figure S3: Forest plot- Subgroup analysis of group educators by individual discipline 
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Supplemental Figure S4: Forest plot- Subgroup analysis of insulin therapy  
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 Supplemental Figure S5: Forest plot- Sensitivity analysis: overall risk of bias 
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Supplemental Figure S6: Forest plot- Sensitivity analysis: reporting bias 
 
 24 
Supplemental Figure S7: Forest plot- Sensitivity analysis: baseline differences 
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Supplemental Figure S8: Forest plot- Sensitivity analysis: attrition 
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Supplemental Figure S9: Forest plot- Sensitivity analysis: published in non-English journals 
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Supplemental Table S4: Summary of meta-analysis results of secondary outcomes assessed using standard mean difference at various time points  
Outcome  Time point 
(mths) 
N 
studies 
N participants 
(IG/ CG) 
Standard Mean 
Difference (95% CI) 
P-value Heterogeneity 
(I2) 
Heterogeneity 
(P-value) 
QOL 6-10  5 135/ 130 -0.03 (-0.34, 0.29) 0.86 34% 0.19 
Depression  6  3 201/ 176 -0.62 (-0.93, -0.31) 0.0001 28% 0.25 
Energy intake  6 5 182/ 203 -0.11 (-0.44, 0.22) 0.50 58% 0.05 
 12  4 389/ 406 -0.21 (-0.58, 0.16) 0.27 84% 0.0003 
Physical activity 6  7 619/ 478 0.23 (0.10, 0.36) 0.0006 9% 0.36 
 12-14 3 486/ 376 0.21 (0.06, 0.35) 0.005 11% 0.33 
N= number; IG= intervention group; CG= control group; CI= confidence interval; QOL= quality of life; mths= months. 
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Supplemental Table S5: Meta-regression: association between study variables and primary outcome 
measure (HbA1c) (n=11) 
Study variable Univariate Analyses 
Coefficient 95% CI P-value 
Theoretical model (RC: Yes)    
No -0.0240 -0.43, 0.38 0.91 
Type of educators (RC: Multidisciplinary team)    
Nurse only -0.4849 -1.16, 0.19 0.15 
Dietitian only -0.2418 -1.10, 0.62 0.57 
Physician only -0.1989 -0.88, 0.48 0.56 
Psychologist only 0.8659 -0.66, 2.40 0.26 
Peer or lay led 0.2516 -0.40, 0.90 0.44 
HP led with peer support -0.4977 -1.17, 0.17 0.14 
Pharmacist only 0.1059 -1.18, 1.40 0.87 
Training (RC: Yes)    
No 0.0428 -0.42, 0.51 0.85 
Materials (RC: Yes)    
No 0.0349 -0.53, 0.60 0.90 
Delivery setting (RC: Primary care)    
Other setting -0.1574 -0.61, 0.30 0.49 
Baseline HbA1c levels (RC: >7% in both groups)    
<7% in both groups 0.2164 -0.29, 0.72 0.39 
Intervention length (RC: <1 mth)    
1-3 mths 0.1308 -0.61, 0.87 0.72 
4-6 mths 0.1181 -0.59, 0.82 0.74 
7-12 mths -0.1945 -0.88, 0.49 0.57 
13-60 mths -0.3246 -1.04, 0.39 0.37 
Number of sessions (RC: < 5 sessions)    
6-10 sessions 0.305 -0.16, 0.77 0.20 
11-20 sessions 0.0122 -0.58, 0.61 0.97 
> 21 sessions -0.4054 -1.13, 0.32 0.26 
Number of participants (RC: 4-10)    
11-20 0.2290 -0.20, 0.66 0.29 
Contact time  (RC: 8 or less hrs)    
9-12 hrs 0.1286 -0.53, 0.79 0.70 
13-18 hrs 0.2705 -0.31, 0.85 0.35 
19-30 hrs 0.0715 -0.55, 0.70 0.82 
31 hrs or more -0.1218 -0.75, 0.51 0.70 
Family and friends (RC: Yes)    
No 0.1436 -0.27, 0.56 0.49 
RC: reference category; CI= confidence interval; HbA1c= glycated haemoglobin; mths= 
months; hrs= hours 
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